Skip to main content

SurpassMD vs Remedy Meds: Flat Low Pricing vs Premium Access

SurpassMD and Remedy Meds sit at opposite ends of compounded GLP-1 pricing. SurpassMD offers semaglutide as low as $114/month and tirzepatide as low as $177/month — flat rates that stay the same across every dose — plus 48-hour cold shipping and a needle-free oral semaglutide option. Remedy Meds charges $299 and $399 per month respectively, billed month-to-month, and its differentiator is unlimited provider messaging and video access at the highest price in this set. Remedy Meds also drew a September 2025 FDA warning letter over marketing that implied its compounded meds were FDA-approved equivalents. The comparison comes down to what that unlimited provider access is worth to you.

Side-by-Side Comparison (July 2026)

FeatureSurpassMDRemedy Meds
SemaglutideAs low as $114/mo$299/mo
TirzepatideAs low as $177/mo$399/mo
Dose escalationFlat — no increase with doseFlat monthly rate
Oral optionOral semaglutide (needle-free)None
Brand-name optionNoneOzempic $1,299, Zepbound $1,399
Provider accessAsync review + supportUnlimited video + messaging
BillingMonth-to-month, cancel anytimeMonth-to-month
PaymentCash-pay; HSA/FSA & KlarnaCash-pay
ShippingCold, within 48 hours3-7 business days
Regulatory historyNew brand (2026), no actionsFDA warning letter Sept 2025 (marketing)
Coverage50 states + DCMost states

What the $175-215/Month Premium Actually Buys

Remedy Meds' unlimited-access model is the entire value proposition. In practice, most GLP-1 patients contact their provider heavily in months one to three (titration, nausea management, injection questions) and rarely after stabilizing. That usage curve suggests a hybrid strategy: if you expect a rough adjustment period, Remedy's access has value early; once stable, SurpassMD's flat rate delivers the identical molecule for far less — and because SurpassMD's price stays the same across every dose, that saving does not erode as you titrate up. Provider-switching between telehealth platforms is routine — the new platform re-runs intake and continues your current dose.

For managing the side effects that drive most provider contact, see our guides to GLP-1 side effects and how long semaglutide side effects last.

Verdict: Which Should You Choose?

SurpassMD wins on price — a flat low rate that does not climb with your dose — plus shipping speed and the oral semaglutide option, all with cancel-anytime billing. Remedy Meds earns its premium only for patients who will genuinely use unlimited provider access or want brand-name medication on the same platform. The September 2025 FDA warning letter is worth weighing when evaluating how each platform communicates about compounded medication risk.

Full reviews: SurpassMD review and Remedy Meds review. See the ranked best GLP-1 telehealth providers and the full price comparison.

Frequently Asked Questions

SurpassMD is $185/month cheaper for compounded semaglutide (as low as $114 vs $299) and $222/month cheaper for compounded tirzepatide (as low as $177 vs $399). Over a 12-month course, that is roughly $2,220-2,664. SurpassMD prices are flat — the same low rate applies across every dose, with no increase as you titrate up. Remedy Meds bills month-to-month only, with no prepay tiers.

Unlimited video calls and messaging with the care team between monthly check-ins — genuinely unusual in the category, where most platforms cap provider contact. Remedy Meds also offers brand-name Ozempic ($1,299) and Zepbound ($1,399), which SurpassMD does not. For patients who expect heavy side-effect management or frequent titration questions, unlimited access has real value.

Yes. In September 2025 the FDA cited Remedy Meds for misbranding: marketing that implied its compounded semaglutide and tirzepatide were FDA-approved equivalents of brand-name drugs. The letter concerned advertising claims, not product safety findings, and the company continues to operate. It is still a relevant signal about marketing practices when comparing platforms.

No. SurpassMD pricing is flat — compounded semaglutide as low as $114/month and tirzepatide as low as $177/month, and that rate does not rise as you titrate to a higher dose. The "as low as" rate reflects the longest-subscription option. You can cancel anytime. Remedy Meds bills a single month-to-month rate with no prepay tiers.

SurpassMD ships cold-chain within 48 hours of provider approval to all 50 states plus DC; Remedy Meds quotes 3-7 business days. Both ship compounded injectables cold-packed with tracking, and both include shipping in the monthly price. SurpassMD also supports HSA/FSA and Klarna, and includes nutrition guidance.

On price, SurpassMD wins this matchup at every point of comparison, with a flat low rate that does not climb as your dose increases, plus 48-hour shipping and an oral semaglutide option. Remedy Meds makes sense for patients who specifically want unlimited provider access or a brand-name option on the same platform, and who will pay $175-215/month more for it. If you rarely message your provider, that premium buys nothing.

Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. A prescription is never guaranteed; eligibility is determined by an independent licensed provider.